- COVID-19 —
- coronavirus disease 2019
- LUS —
- lung ultrasound
The novel coronavirus disease 2019 (COVID-19) is rapidly spreading all around the world, affecting both adults and children. Recently, the clinical and radiographic characteristics of children infected have been described.1 Although lung ultrasound (LUS) is recognized as a valid imaging technique for the diagnosis and follow-up of pneumonia in pediatric age,2 no data are currently available about LUS use in children with COVID-19. Considering the well-known advantages of point-of-care ultrasound,3 including the possibility of reducing the patient’s movement across the hospital department, we investigated LUS findings in children infected with severe acute respiratory syndrome–coronavirus 2.
Methods
We performed an observational study at Regina Margherita Children’s Hospital (Turin, Italy). Children and adolescents (0–17 years) admitted to the pediatric infectious diseases department for documented COVID-19 were analyzed. Epidemiological, clinical, and laboratory data were collected, and we categorized patients according to the clinical definitions recently provided by Qiu et al.1 LUS was performed during the routine medical examination with a linear array transducer at 7.5 to 13 MHz (MyLab Seven; Esaote, Genoa, Italy), applying the Copetti protocol.4
Results
Between March 18 and March 26, 2020, 8 children affected by COVID-19 were admitted to our department. Epidemiological and clinical features are provided in Table 1. Two cases (25%) were classified as severe clinical types, 2 (25%) as moderate, and 4 (50%) as mild. Two (25%) children needed noninvasive oxygen administration for 2 and 4 days, respectively. None of them required mechanical ventilation. We performed LUS in all 8 patients, paying particular attention to signs of viral pneumonia as small subpleural consolidations and/or individual B-lines or confluent B-lines (echogenic vertical lines arising from the pleural line and moving in concert with a sliding lung, expression of an interstitial syndrome).5 LUS revealed subpleural consolidations in 2 children and confluent B-lines in 5 children. In 7 of 8 patients, we found a concordance with the radiologic findings (Fig 1), whereas in the remaining patient, an interstitial B-lines pattern was observed despite a normal chest radiography. One patient with severe clinical type was repeatedly examined with LUS on alternate days, and we noted a B-lines bilateral pattern reduction a day in advance before clinical and radiographic improvement.
Epidemiological and Clinical Features of COVID-19 Pediatric Patients Stratified by Clinical Types
A and B, Multiple confluent B-lines (thin arrows). C, Chest radiography with left upper lobe consolidation and right central ground-glass opacities. D and E, A lung consolidation (thick arrows) at LUS.
In the 7 children with pathologic ultrasound imaging at baseline, LUS was repeated before discharge and revealed improvement or resolution of consolidations (2 of 2) and interstitial patterns (5 of 5), which was consistent with the concomitant radiologic findings.
Conclusions
Investigators have shown that in adults with COVID-19 pneumonia, bedside ultrasound correlates with computed tomography findings.6 Our study represents a preliminary report of LUS characteristics in children affected by COVID-19. Although the number of patients analyzed is small, the high concordance between radiologic and LUS findings suggests that ultrasound may be a reasonable method to detect lung abnormalities in children with COVID-19. LUS may be useful in the management of children with COVID-19 for several reasons. First, it may reduce the number of radiologic examinations, lowering the radiation exposure of the patients. Secondly, when performed at the bedside, LUS allows for the reduction of the patient’s movement within the hospital; thus, it lowers the number of health care workers and medical devices exposed to severe acute respiratory syndrome–coronavirus 2. Moreover, the recent evolution in the ultrasound field allows for the use of wireless devices, which, when available, are probably the most appropriate ultrasound equipment in patients with confirmed or suspected COVID-19. Both the wireless probe and the tablets are easily wrapped in disposable plastic covers, allowing for simple sterilization procedures and reducing the risk of contamination, as recently suggested by Buonsenso et al.7
In conclusion, although additional studies are needed to better understand and characterize LUS findings in this novel disease in children, we propose routine LUS protocol examinations as a useful tool in the diagnostic and clinical management of mild or severe COVID-19 in children.
Acknowledgments
We thank Drs A.G. Delmonaco and E. Garrone for their constant ultrasound teaching activity at pediatrics resident.
Footnotes
- Accepted April 16, 2020.
- Address correspondence to Marco Denina, MD, Paediatric Infectious Diseases Unit, Regina Margherita Children’s Hospital, University of Turin, Piazza Polonia 94, 10126 Turin, Italy. E-mail: marco.denina{at}gmail.com
FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.
FUNDING: No external funding.
POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.
References
- Copyright © 2020 by the American Academy of Pediatrics
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.